Clinical Trial Update: Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Phase 1/2 study evaluating cord blood mononuclear cells as a treatment for delayed encephalopathy after carbon monoxide poisoning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Encephalopathy After Carbon Monoxide Poisoning

Drugs mentioned

• Cord blood mononuclear cell therapy

Snippet

Sponsor: Liaocheng People's Hospital | Conditions: Delayed Encephalopathy After Carbon Monoxide Poisoning | Phase 1, Phase 2 | Status: UNKNOWN